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Abstract
Background: We have reported previously that when chromosome Y (chrY) from the mouse strain
C57BL/6J (ChrYC57) was substituted for that of A/J mice (ChrYA), cardiomyocytes from the resulting
"chromosome substitution" C57BL/6J-chrYA strain were smaller than that of their C57BL/6J counterparts.
In reverse, when chrYA from A/J mice was substituted for that of chrYC57, cardiomyocytes from the
resulting A/J-chrYC57 strain were larger than in their A/J counterparts. We further used these strains to
test whether: 1) the origin of chrY could also be linked to differences in the profile of gene expression in
the hearts of adult male mice, and 2) post-pubertal testosterone could play a role in the differential
morphologic and/or molecular effects of chrYC57 and chrYA.
Results: The increased size of cardiomyocytes from adult male C57BL/6J mice compared to C57BL/6J-
chrYA resulted from the absence of hypertrophic effects of post-pubertal testosterone on cells from the
latter strain. However, gene profiling revealed that the latter effect could not be explained on the basis of
an insensitivity of cells from C57BL/6J-chrYA to androgens, since even more cardiac genes were affected
by post-pubertal testosterone in C57BL/6J-chrYA hearts than in C57BL/6J. By testing for interaction
between the effects of surgery and strain, we identified 249 "interaction genes" whose expression was
affected by post-pubertal testosterone differentially according to the genetic origin of chrY. These
interaction genes were found to be enriched within a limited number of signaling pathways, including: 1)
p53 signaling, which comprises the interacting genes Ccnd1, Pten and Cdkn1a that are also potential co-
regulators of the androgen receptors, and 2) circadian rhythm, which comprises Arntl/Bmal1, which may in
turn regulate cell growth via the control of Cdkn1a.
Conclusion:  Although post-pubertal testosterone increased the size of cardiomyocytes from male
C56BL/6J mice but not that from their C57BL/6J-chrYA counterparts, it affected gene expression in the
hearts from both strains. However, several cardiac genes responded to post-pubertal testosterone in a
strict strain-selective manner, which provides possible mechanisms explaining how chrY may, in part via
interference with androgen regulatory events, be linked to morphologic differences of cardiac cells of adult
male mice.
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Background
Chromosome Y (chrY) stands out from all other chromo-
somes: it is comprised for most of its length of sequences
that do not recombine (the so-called "male-specific
part"), it contains many repetitive DNA sequences of
unclear significance, and it harbors only a small number
of active genes [1]. Genes from the male-specific part of
chrY are clearly not essential for life, as demonstrated in
female organisms. Besides Sry  (the master gene in sex
determination), most of what is known about the func-
tions of other chrY genes relates to their effects on male
reproductive and sex accessory organs [2-4]. Nonetheless,
genetic variants of chrY have been shown to have an
impact on functions unrelated to male reproductive biol-
ogy, including the severity of experimental allergic
encephalomyelitis in mice [5], the incidence of prostate
cancer in humans [6,7], and several cardiovascular condi-
tions such as hypertension and high plasma cholesterol in
either humans or animal models [8-10]. The mechanism
explaining these particular effects of chrY genes are still
unclear, and cannot be explored by using classical genetic
methods because chrY genes do not recombine.
Recently, we have reported that chrY accounts for a large
part of the genetic variance of the size of adult male heart
muscle cells [i.e. cardiomyocytes (CMs)] isolated from
mice derived from crosses between A/J and C57BL/6J [11].
In agreement with the linkage mapping results, we also
found that when chrY from the parental strain C57BL/6J
(ChrYC57) was substituted for that of A/J mice (ChrYA),
CMs from the resulting "chromosome substitution" (or
"consomic") C57BL/6J-chrYA strain (C57.YA) were smaller
than that of their C57BL/6J counterparts. In reverse, when
chrYA from A/J mice was substituted for that of chrYC57,
CMs from the resulting A/J-chrYC57 strain (A.YC57) were
larger than in their A/J counterparts. Since the only genetic
differences in these unique animal models are those pos-
sibly existing between C57BL/6J and C57.YA, we used
these strains to further test whether, in addition to affect-
ing the size of CMs, the origin of chrY could also be linked
t o  d i f f e r e n c e s  i n  t h e  p r o f i l e  o f  g e n e  e x p r e s s i o n  i n  t h e
hearts of adult male mice. Moreover, since: 1) one of the
most obvious consequences of chrY is to foster the devel-
opment of male gonads and the production of testoster-
one, and 2) there is preliminary evidence that chrY
polymorphisms may interfere with some biologic effects
of testosterone [10,12], we tested whether postpubertal
testosterone could play a role in the differential morpho-
logic and/or molecular effects of chrYC57 and chrYA on car-
diac cells.
Results and discussion
In extension to our previous findings showing that CMs
from strains carrying chrYC57 were larger than that from
their counterparts carrying chrYA [11], we found that pre-
pubertal castration (which prevents the increase in plasma
testosterone that normally occurs at puberty) decreased
the size of CMs in adult animals from strains carrying YC57
(i.e. C57BL/6J and A.YC57 mice), but not in their counter-
parts carrying chrY from A/J (YA), i.e. A/J and C57.YA mice
(Figure 1). The effect of castration (CX) was not the result
of testosterone production being higher in C57BL/6J
mice, as plasma testosterone in adult male C57BL/6J mice
(2.5 ± 1.7 ng/ml) was in fact lower than in their A/J (10.8
± 3.6) or C57.YA (9.6 ± 4.5) counterparts, this result being
in agreement with another report showing that the levels
of plasma testosterone are lower in male C57BL/6J mice
than in several other mouse inbred strains [13]. Likewise,
the abundance of androgen receptor mRNA and protein
was similar in the hearts of all strains (not shown). How-
ever, chronic treatment of mice that had been castrated at
3 weeks of age with 2 dosages of testosterone from 8 to 12
weeks of age increased the size of CMs of C57BL/6J in a
dose-dependent fashion, but not in the consomic strain
C57.YA (Figure 2). In contrast, testosterone also increased
the size of CMs from consomic A.YC57 in a dose-depend-
ent fashion, although we had found that cardiomyocytes
from the parental A/J strain were not affected by CX. Alto-
gether, these results showed that the difference in size of
CMs from intact (sham-operated) C57BL/6J and C57.YA
male mice resulted from the fact that cardiomyocytes
from C57.YA were not sensitive to the hypertrophic effects
of post-pubertal testosterone.
We next compared the cardiac transcriptosomes of 4
sham-operated and 4 CX adult male mice from the
C57BL/6J and C57.YA strains. The numbers of probes and
corresponding genes showing differential expression
between groups (selected on the basis of a FDR < 0.1) are
summarized in Table 1. We found that the effects of post-
pubertal testosterone and/or the origin of chrY affected
the profile of cardiac gene expression in a manner that was
Surface area of cardiomyocytes from 12 week-old male A/J,  C57BL/6J, A/J.YC57 or C57.YA mice Figure 1
Surface area of cardiomyocytes from 12 week-old 
male A/J, C57BL/6J, A/J.YC57 or C57.YA mice. All ani-
mals have undergone surgery (either sham or castration) at 4 
weeks of age. The figures represent values for individual ani-
mals scattered around the mean value of the group. ***P < 
0.001 vs. sham-operated.
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very different than their respective effects on the size of
CMs. For instance, although post-pubertal testosterone
had no effect on the size of CMs from C57.YA male mice,
it affected the expression level of many cardiac genes in
that strain, and even of a greater number of genes than in
their C57BL/6J counterparts. This indicated that the lack
of hypertrophic effects of post-pubertal testosterone on
CMs from C57.YA was not the manifestation of an insen-
sitivity of cells from this strain to androgens, but rather
the result of a differential molecular response to the hor-
mone. Likewise, despite the fact that the effect of chrY on
the size of CMs was observed only in sham intact C57BL/
6J mice but not in their CX counterparts, more cardiac
genes showed chrY-dependent differential expression in
CX than in sham intact animals. This indicated that the
presence of post-pubertal testosterone was not required in
order to observe an effect of chrY. Finally, in addition to
the marginal effects of strain and surgery, we also tested
for interaction between these two factors, which allowed
us to identify within the genome 249 unique genes (here-
after referred to as "interaction genes") whose expression
was affected by CX (and thus by post-pubertal testoster-
one) differentially according to the genetic origin of chrY
(Additional file 1). Most interactions genes showed rather
large differences in gene expression, as ~44% of them dis-
played either strain-dependent differences or surgery-
dependent changes were greater than 1.5 fold. To validate
the results of the microarray analysis, we performed real-
time RT-PCR quantifications for 6 of the interaction
genes. The differences detected by RT-PCR were similar to
those that had been detected with the microarray (Figure
3).
To further determine 1) which particularly surgery group
comprised genes where the strain-dependent differences
in expression varied according to the surgery status, and 2)
to which particular strain corresponded genes where the
Surface area of cardiomyocytes from 12 week-old male A/ J.YC57, C57BL/6J or C57.YA mice Figure 2
Surface area of cardiomyocytes from 12 week-old 
male A/J.YC57, C57BL/6J or C57.YA mice. All animals 
have undergone surgery (either sham or castration) at 4 
weeks of age, and were treated with testosterone cypionate 
(either 0.5 mg or 2 mg/kg body weight) from 8 to 12 weeks 
of age. The figures represent values for individual animals 
scattered around the mean value of the group. **P < 0.01; 
***P < 0.001.
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Real-time RT-PCR quantifications of 6 genes in the hearts of adult male C57BL/6J and C57.YA (either intact sham-operated of  castrated) Figure 3
Real-time RT-PCR quantifications of 6 genes in the hearts of adult male C57BL/6J and C57.YA (either intact 
sham-operated of castrated). *P < 0.05; **P < 0.01; *P < 0.001 (Bonferroni-corrected post-hoc tests).
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effect of CX varied according to the origin of chrY, we per-
formed post-hoc analyses on the hybridization results
obtained with probes from all interaction genes. Accord-
ingly, we found that the expression of interaction genes
was differentially affected by strain to a greater extent in
CX (177/249 genes) than in intact sham (99/249 genes)
mice (with 3 genes where the effect of surgery treatment
did not reach significance with the post-hoc analysis) (Fig-
ure 4). Likewise, genes responded to CX in a strain-specific
manner to a greater extent in C57.YA (204/249 genes)
than in C57BL6/J (77 genes/249) mice (with also 3 genes
where the effect of strain did not reach significance with
the post-hoc analysis) (Figure 4).
In order to assess the biological significance of the interac-
tion genes, we performed a Set Enrichment Test for every
pathway in the Kyoto Encyclopedia of Genes and
Genomes (KEGG) [14] to calculate the probability of
observing a given number of selected genes in a pathway
by chance. The six following KEGG pathways showed
enrichment for interaction genes using a p-value ≤ 0.05 as
a criteria for selection: circadian rhythm [containing Arntl1
(also known as Bmal1), Per2, Per3 and Cry2], p53 signaling
pathway (containing Cdkn1a, Gadd45g, Ccnd1 and Pten),
melanoma (also containing Cdkn1a, Ccnd1 and Pten, as
well as Fgf7), cytokine-cytokine receptor interaction (contain-
ing Acvr2b, Ccl8, Tnfrsf12a, Cxcl1 and IL28ra), leukocyte
Table 1: Numbers of probes and corresponding unique genes in different conditions
Condition Probes Corresponding unique genes
Present on Mouse Ref-8 25,697 18,118
Detected (in at least one out of four conditions) 12,764 8,297
Surgery: overall effect 3,030 2,274
Surgery: effect in C57BL/6J 1,103 845
Surgery: effect in C57.YA 2,706 2,042
Strain: overall effect 3,282 2,508
Strain: effect in CX 3,209 2,421
Strain: effect in sham (intact) 479 381
Interaction between surgery and strain 318 249
Venn diagrams showing the distribution of "interaction genes" within the 2 particular surgery groups or within the 2 particular  strains used in the current study (n = 4 per group) Figure 4
Venn diagrams showing the distribution of "interaction genes" within the 2 particular surgery groups or within 
the 2 particular strains used in the current study (n = 4 per group).BMC Genomics 2009, 10:150 http://www.biomedcentral.com/1471-2164/10/150
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transendothelial migration (containing Myl7, Cldn5, Jam5
and Vcam1), and tight junction (also containing Myl7 and
Cldn5, as well as Jam2, Pten and Myh7) (see Additional file
2 and Table 2). However, it should be noted that there is
some overlap between the groups of genes assigned by
KEGG to each pathways: melanoma shares 5 genes with
either  p53 signaling pathway or  cytokine-cytokine receptor
interaction, it also shares 3 genes with tight junction, and
the latter shares 20 genes with leukocyte transendothelial
migration. This is likely to result from the fact that the
KEGG classification is somewhat arbitrary, and some-
times assigns genes on the basis of particular biologic
manifestations rather than regulatory pathways or func-
tions. Nonetheless, overlap between KEGG pathways sug-
gests that a common biological process underlies the
selection of these particular genes. Of note, one additional
limitation of the Set Enrichment Test is that the coverage
of KEGG pathways is still incomplete at the current time.
For instance, although Dbp, Tef, Nr1d2 and Rora are all
well-known downstream effectors of clock genes [15,16],
none of them have been included yet within the KEGG cir-
cadian rhythm pathway. Likewise, Myl4  has not been
assigned to either leukocyte transendothelial migration or
tight junction despite being highly homologous to Myl7.
Interestingly, 14 out of the 17 interaction genes enriched
within KEGG pathways display strain-dependent differ-
ences or surgery-dependent changes that were greater than
1.5 fold (see Additional file 2), which may constitute one
other indication that these particular genes play biologi-
cally important roles.
Circadian rhythm, in addition to being the KEGG pathway
showing the most significant enrichment for interactions
genes, also comprised genes showing some of the largest
differences in expression among interaction genes. If we
consider all 14 genes that could be classified as "circa-
dian" on the basis of both KEGG pathway database and
additional annotation from the literature, we found that
expression of 14 of them were significantly affected by CX
in C57.YA mice in contrast to only one gene in C57BL/6J
(Table 3 and Figure 5). Although only 10 genes were
included in the interaction genes set, the post-hoc tests
revealed evidence for interaction in two extra circadian
genes, i.e. Csnk1e and Csnk1d, that showed 20% increase
in castrated animals but only in the C57.YAstrain. As a
consequence of this differential response to post-pubertal
testosterone, most circadian genes showed strain-depend-
ent differences in cardiac expression between intact
C57BL/6J and C57.YA mice, but not in their CX counter-
parts (Figure 6). One caveat concerning these experimen-
tal results is that expression of circadian genes is, by
definition, very sensitive to time. Although we took care of
killing all mice at the same time of day (between 9:00 and
10:00 AM), further validation requires additional experi-
ments using mice from both strains killed at different
times of the 24-hour nyctemer. Nonetheless, there are cur-
rently other lines of evidence suggesting that the current
results are biologically pertinent, since: 1) recent reports
showed that androgens are major regulators of clock
genes in C57BL/6J mice and that they are responsible for
sex-dependent differences in circadian activity [17,18],
and 2) male C57BL/6J mice do not show (in contrast to
male A/J counterparts) circadian oscillations of heart rate
(corrected for locomotor activity) [19]. Moreover, it has
also been reported recently that Arntl/Bmal1 is a major reg-
ulator of Cdkn1a (whose expression is also greatly affected
by CX in a C57.YA-specific fashion, as discussed below)
and that Arntl-dependent changes in the concentration of
the corresponding p21Waf1/Kip1 protein correlate with
changes in the rate of liver cell proliferation, in keeping
with the known functions of this cyclin inhibitor [16].
Within the p53 signaling pathway (second in importance
in terms of enrichment for interacting genes), Ccnd1, Pten
and Cdkn1a may be of particular interest. Indeed, Ccnd1
encodes for cyclin D1 which is considered as one of the
few bona fide AR-specific co-repressors, both in androgen-
dependent and-independent environments [20-22]. Cyc-
lin D1 (down-regulated in CX C57BL/6J vs. CX C57.YA)
can be silenced by Akt [23], and the latter may be more
active in CX C57BL/6J because its inhibitor Pten is down-
regulated vs. CX C57.YA. Cyclin D1 can also be silenced
by the p21Waf1/Kip1 cyclin inhibitor protein (encoded
by Cdkn1a) [24], the latter being upregulated in CX
Table 2: Selected KEGG pathways showing enrichment for interaction genes
KEGG ID Term Size Expected Count Count P-value
4710 Circadian rhythm 10 0.33 6 1.8E-07
4115 p53 signaling pathway 31 1.02 5 0.0028
5218 Melanoma 32 1.05 4 0.0190
4060 Cytokine-cytokine receptor interaction 70 2.30 6 0.0249
4670 Leukocyte transendothelial migration 52 1.71 5 0.0257
4530 Tight junction 73 2.40 6 0.0299
Listed KEGG pathways correspond to those showing significant enrichment (p < 0.05) for "interaction genes". Size corresponds to the number of 
genes assigned by KEGG within each particular pathway. Expected count corresponds to the number of interaction genes could be expected to be 
found if there was no significant enrichment, count corresponds to the effective number of genes showing significant enrichment (p < 0.05) (see also 
Additional file 2).BMC Genomics 2009, 10:150 http://www.biomedcentral.com/1471-2164/10/150
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C57BL/6J vs. CX C57.YA. Finally, an active Akt pathway
may stimulate the androgen pathway in part via phospho-
rylation of the androgen receptor [25]. If all these strain-
dependent differences in gene expression in CX animals
translate into changes at the protein level, the balance
between co-repressors and co-activators would tip
towards the latter in CX male C57BL/6J mice (Figure 7).
Of note, some degree of constitutive activation of the AR
in CX male C57BL/6J might explain why fewer genes
respond to post-pubertal T in this strain than in C57.YA
mice, and why there are fewer differences in gene expres-
sion in intact C57BL6/J and C57.YA than in their CX
counterparts. Likewise, increased sensitivity of the AR
might explain why plasma testosterone is lower in intact
C67BL6/J than in C57.YA mice, as measured by ourselves
(data not shown) and in agreement with a previous report
[13].
Expression of Cdkn1a is increased ~5-fold in the hearts of
intact vs. CX C57.YA (see Additional file 1), which is in
keeping with previous reports showing that this gene is an
important target of activated androgen receptors [26].
However, there was also striking strain-selectivity in the
response, as there are no changes in expression between
intact and CX C57BL/6J mice. Interestingly, Cdkn1a
(which encodes for a well-known regulator of cell growth)
has been shown to escape from androgen-dependence in
some types of prostate cancers, and this phenomenon has
been implicated as one of the possible factors leading to
an increase in the growth properties of these cells [27-29].
Although cardiac cells are post-mitotic, p21 may act on
these cells as a negative regulator of hypertrophy [24,30].
The lack of response of Cdkn1a to post-pubertal testoster-
one in C57BL/6J might thus provide an explanation for
why pubertal androgens increase the size of cardiomyo-
cytes in this strain, but not in C57.YA.
Thirteen genes have been reported on the male-specific
portion of mouse chrY. The short arm of mouse chrY (Yp,
~2.5 Mb) contains the best characterized sequences to
date, i.e. Sry and the 9 following genes: Ube1y1, Zfy1, Zfy2,
Jarid1d, Eif2s3y, Uty, Ddx3y, Usp9y and Rbmy1a1 [31].
Three other genes, i.e. Ssty1, Ssty2 and Sly, are present on
Probe expression pattern for circadian genes (either genes  listed in the KEGG pathway mmu04710 circadian rhythm or  interaction genes described as circadian in the literature) Figure 5
Probe expression pattern for circadian genes (either 
genes listed in the KEGG pathway mmu04710 circa-
dian rhythm or interaction genes described as circa-
dian in the literature). Each line connects average 
expression of a given gene between CX and sham operated 
mice. Strain of mice is denoted by a solid line, for C57BL/6J 
and a dashed line for C57.YA. The vertical scale corresponds 
to log2 (hybridization intensity value). For the 8 genes listed 
in the left part of the figure (with a different color for each 
symbol and corresponding lines), the difference between the 
slopes of the lines reflects the interaction effects. For 4 addi-
tional genes (listed in the right part of the figure, with sym-
bols and corresponding lines formatted in gray), there is no 
significant interaction effect.
Expression of Circadian Rhythm Genes
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A
Diagram summarizing circadian clock genes that are differen- tially expressed in hearts from intact sham-operated C57BL/ 6J and C57.YA mice Figure 6
Diagram summarizing circadian clock genes that are 
differentially expressed in hearts from intact sham-
operated C57BL/6J and C57.YA mice. Boxes are in red 
or green when gene expression is higher in intact male 
C57.YA or C57BL/6J mice, respectively. Lines terminating 
with an arrowhead indicate positive regulation; those termi-
nating with a bar indicate negative regulation. The values rep-
resent the ratio of mRNA abundance in intact (sham-
operated) male C57.YA vs. C57BL/6J hearts.BMC Genomics 2009, 10:150 http://www.biomedcentral.com/1471-2164/10/150
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the long arm (Yq) in multiple copies [32,33]. Out of these
13 genes, we found only 5 of them to be expressed in
hearts, i.e. Ddx3y, Uty, Eif2s3y, Jarid1d and Sly (data not
shown). These genes appear to be expressed in a ubiqui-
tous fashion, as we have detected by RT-PCR correspond-
ing amplification products in many other non-cardiac
tissues (listed below in the Methods section; data not
shown). The first four of these genes were present on the
Illumina MouseRef-8 v2.0 BeadChip, whose analysis
revealed possibly significant differences among experi-
mental groups. For Ddx3y, the effect of strain was signifi-
cant (P < 0.05), but not that of surgery nor the interaction
between the two. For Eif2s3y, the interaction (but not
strain or surgery) was significant (P < 0.01). However,
quantification of the level of expression of Ddx3y  and
Eif2s3y in the same samples by quantitative RT-PCR did
not reveal any significant effect of strain or surgery in
hearts from adult mice (Figure 8). We also measured by
quantitative RT-PCR the level of expression of all 5 genes
in hearts of C57BL.6J and C57.YA mice at different times
during development. At the time of birth (but at no other
tested time), both Ddx3y and Eif2s3y showed lower levels
of expression in hearts from C57BL/6J male mice com-
pared to their C57.YA counterparts (Figure 9). However,
no polymorphism was found between the 2 strains for the
regions including ~1 kb of upstream promoter and each
exon (including 30 bp of intron flanking sequences as
well as ~1 kb of the 3'-untranslated region). It therefore
remains to be determined whether the perinatal differ-
ences in expression of these two chrY genes may relate to
differences in the effects of post-pubertal testosterone dur-
ing adult life, and if so, by which mechanism. Likewise,
which polymorphisms on chrY may be responsible for
such differences needs additional sequencing.
Conclusion
The increased size of cardiomyocytes from adult male
C57BL/6J mice compared to C57BL/6J-chrYA  resulted
from the absence of hypertrophic effects of post-pubertal
testosterone on cells from the latter strain. However, gene
profiling revealed that the lack or hypertrophic effects
Table 3: Summary of results concerning circadian genes
C57BL/6J C57.YA Interaction
Gene Symbol Gene Name FC FDR FC FDR FDR
Arntl aryl hydrocarbon receptor nuclear translocator-like -1.10 0.531 -5.30 0.000 0.006
Dbp D site albumin promoter binding protein -1.05 0.772 2.94 0.000 0.006
Tef thyrotroph embryonic factor 1.02 0.851 2.16 0.001 0.008
Per2 period homolog 2 (Drosophila) 1.11 0.531 2.95 0.001 0.009
Cry2 cryptochrome 2 (photolyase-like) -1.08 0.370 1.42 0.001 0.019
Clock circadian locomoter output cycles kaput -1.10 0.284 -1.62 0.001 0.024
Nr1d2 nuclear receptor subfamily 1, group D, member 2 1.08 0.561 1.84 0.001 0.033
Per3 period homolog 3 (Drosophila) 1.08 0.503 1.67 0.001 0.034
Rora RAR-related orphan receptor alpha 1.02 0.845 1.46 0.002 0.081
Per1 period homolog 1 (Drosophila) -1.01 0.923 1.92 0.004 0.087
Csnk1e casein kinase 1, epsilon 1.02 0.826 1.23 0.016 0.230
Csnk1d casein kinase 1, delta 1.04 0.789 1.23 0.061 0.437
Nr1d1 nuclear receptor subfamily 1, group D, member 1 -1.36 0.017 -1.39 0.006 0.920
Bhlhb2 basic helix-loop-helix domain containing, class B2 1.14 0.251 1.15 0.135 0.942
Genes were considered as "circadian" on the basis of information from both the KEGG pathway database and additional annotation from the 
literature. FC: fold change of CX over Sham operated animals; FDR: P-values for the interaction between strain and treatment effects after 
adjustment for multiple comparisons with an FDR transformation (see methods); FDR values < 0.1 are formatted in bold.
Diagram summarizing differences in expression of interaction  genes enriched within the KEGG p53 signaling pathway, and  possible interactions of corresponding proteins with the  androgen receptor Figure 7
Diagram summarizing differences in expression of 
interaction genes enriched within the KEGG p53 sig-
naling pathway, and possible interactions of corre-
sponding proteins with the androgen receptor. Boxes 
are in red or green when gene expression is increased or 
decreased in CX male C57BL/6J mice, respectively. Lines ter-
minating with an arrowhead indicate positive regulation, 
those terminating with a bar indicate negative regulation. The 
values represent the ratio of mRNA abundance in CX male 
C57BL/6J vs C57.YA hearts.
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could not be explained on the basis of an insensitivity of
cells from C57BL/6J-chrYA to androgens, because post-
pubertal testosterone affected the expression of more
genes in hearts from in C57BL/6J-chrYA than in that from
C57BL/6J. Moreover, several cardiac genes responded to
post-pubertal testosterone in a strict strain-selective man-
ner. These findings provide possible mechanisms explain-
ing how chrY may, in part via interference with androgen
regulatory events, be linked to morphologic differences of
cardiac cells of adult male mice. Of note, there are well-
known differences in the manifestations of cardiovascular
diseases between men and women [34,35]. Despite the
important contributions of post-pubertal sex steroids, the
latter do not account for all differences, and there is now
evidence that genes present on sex chromosomes also play
important roles as well [36]. In light of the current data, it
becomes worth testing further to which extent: 1) chrY
related associations can be explained in terms of modula-
tion of the effects of androgens, and 2) chrY may partici-
pate to male/female differences in cardiovascular diseases.
Methods
Experimental animals
All procedures on animals were approved by the Institut
de Recherches Cliniques de Montréal (IRCM) Institu-
tional Animal Care Committee and conducted according
to guidelines issued by the Canadian Council on Animal
Care. All mice were obtained from The Jackson Laboratory
(Bar Harbor, ME). In addition to the parental A/J and
C57BL/6J strains, we used their respective chromosome-
substitution strains (also known as consomic strains) A/J-
chrYC57BL/6J/NaJ and C57BL/6J-chrYA/J/NaJ strains (previ-
ously simply identified as A.YC57 and C57.YA). The latter
corresponded to either A/J or C57BL/6J male mice whose
chrY has been switched by inbreeding for that of the other
strain [37]. To evaluate the effect of post-pubertal testo-
sterone, all animals were operated between 3 and 4 weeks
of age, with castration being performed in some mice to
prevent the rise of testosterone that normally occurs at
puberty, and sham-operated mice being used as controls.
To evaluate the effects of testosterone replacement, all ani-
mals were castrated between 3 and 4 weeks of age, and
subcutaneous injections of either vehicle (i.e. vegetable
oil) or testosterone cypionate (0.5 and 2 mg/kg) were per-
formed 3 times per week between 8 and 12 weeks of age.
Real-time RT-PCR quantifications of the abundance of  mRNA transcripts of Ddx3 and Eif2s3y in the hearts of adult  male C57BL/6J and C57.YA (either intact sham-operated of  castrated) Figure 8
Real-time RT-PCR quantifications of the abundance 
of mRNA transcripts of Ddx3 and Eif2s3y in the 
hearts of adult male C57BL/6J and C57.YA (either 
intact sham-operated of castrated). The figures repre-
sent values obtained with samples from individual animals, 
scattered around the mean of the group.
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Real-time RT-PCR quantifications of the abundance of mRNA transcripts of Ddx3 and Eif2s3y in the hearts of intact male  C57BL/6J and C57.YA taken at different times during development Figure 9
Real-time RT-PCR quantifications of the abundance of mRNA transcripts of Ddx3 and Eif2s3y in the hearts of 
intact male C57BL/6J and C57.YA taken at different times during development. The points represent means ± SD 
(n = 5).BMC Genomics 2009, 10:150 http://www.biomedcentral.com/1471-2164/10/150
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Isolation of CMs and videomicroscopy
CMs were isolated from 12 week-old mouse hearts
mounted for cardiac retrograde aortic perfusion as per-
formed previously [11,38,39]. After fixing, the profiles of
isolated CMs were visualized by autofluorescence (excita-
tion 540 nm, emission 620 nm) and their image captured
with a Retiga EXi monochrome camera (Qimaging, Sur-
rey, BC, Canada). The area, length, width and width/
length ratio of ~100 CMs per heart were measured using
the public domain Java image processing program ImageJ
[40], as described previously [11].
Microarray experiments
Total RNA was extracted, using the RNeasy minikit (Qiagen
Canada, Mississauga, ON), from cardiac left ventricles
obtained from 12 week-old male C57BL/6J or C57.YA that
had undergone either castration or sham surgery between
3 and 4 weeks of age. All animals were killed between 9:00
and 10:00 AM. Four animals were used for each group,
thus providing a total of 16 individual samples. Bioti-
nylated probes were prepared from 50 ng of total RNA,
using the Ambion Illumina TotalPrep RNA Amplification
kit (Applied Biosystems, Streetsville, ON). The probes
were hybridized to two Illumina MouseRef-8 v2.0 Bead-
Chips that carry 8 microarrays each, containing 25,697
probes covering 19,728 non-redundant, well-annotated
RefSeq sequences covered by either one single probe
(79.3%), 2 probes (15%) or 3 or more probes (5.7%).
Raw data (probe unnormalized intensity values) were
obtained using the BeadStudio software (Illumina, San
Diego, CA) and imported into the R 2.7.0 (UNIX) lan-
guage/environment for normalization and analysis.
Quantile normalization was performed using functions
provided by the Affy package, as described [41]. Raw and
normalized data have been deposited into the Gene
Expression Omnibus (GEO) public depository (submis-
sion GSE15354), in accordance with MIAME standards.
To decrease the number of multiple comparisons across
genes, undetected genes were eliminated from the dataset
using Present/Absent calls, as recommended [42]. Detec-
tion probability was estimated with the BeadStudio appli-
cation by using the distribution of intensity values of
negative probes. Transcripts were called as present when
probability of detection was equal or higher than 0.96.
Probes having a "present" call in at least 50% of samples
belonging from any strain and/or surgery group were
selected for further analyses. A linear model including
genotype (strain) and treatment (castration) was fitted to
normalized data: yij = μ + Gi + Tj + I(GxL)ij + eijk, where yij is
the normalized-transformed gene expression, μ  is the
population mean, Gi is the effect of ith genotype, Tj is the
effect of jth castration treatment, I(GxT)ij is the effect of
genotype by treatment interaction, and eijk is the residual
effect. The significance of effects from strain, surgery and
their interaction was tested by appropriate contrasts in a F-
test between groups in a factorial ANOVA design. The F-
tests were calculated with the James-Stein shrinkage esti-
mate using information from neighboring probes [43]. P-
values were calculated by performing 1000 permutation
of samples to break their association to expression values,
then corrected for multiple comparisons by adaptive false-
discovery rate (FDR) transformation [44], using a 10%
FDR cutoff. All computations were done with the R/
Maanova package v. 1.10.0 [45].
The set of probes with significant interaction effects, i.e.
the "Interaction Genes set" was tested for enrichment of
any KEGG pathway in the KEGG database http://
www.genome.ad.jp. Enrichment for KEGG pathways was
tested by comparing the number of genes in a pathway to
what would be expected by chance if the Interacting Genes
set was a random sample from the list of genes present in
samples. Using a hypergeometric function, this probabil-
ity is calculated, which is equivalent to a Fisher's Exact
Test. Genes with multiple probes in the microarrays were
selected if at least one probe presented an FDR < 0.1 for
the interaction term. Genes with multiple probes were
counted only once in this analysis. Pathways with a p-
value ≤ 0.05 were selected. Computations were performed
with the GOstats package for R [46].
PCR and RT-PCR amplification of total RNA
To verify which chrY genes were expressed in the heart
and/or other tissues, total RNA was extracted from several
tissues of adult C57BL/6J mice using the RNeasy minikit
(Qiagen Canada, Mississauga, ON). The tissues were the
left cardiac ventricles, quadriceps muscle, small and large
intestine, brain, thymus, lungs, kidneys, pancreas, adrenal
glands, testes, peritoneal fat and bladder. Complementary
DNA was then synthesized (using 2 μg of total RNA from
each tissue) using Superscript II reverse transcriptase (Invit-
rogen Canada, Burlington, ON), and 100 ng of cDNA
from each sample was then PCR amplified. Each primer
pairs was designed to overlap at least one exon (with the
exception of Sry, which is comprised of a single exon).
Amplification products were visualized by UV illumina-
tion of products electrophoresed in an agarose gel con-
taining ethidium bromide. Primers used for amplification
of chrY of cDNA reverse-transcribed from chrY gene
mRNA transcripts are summarized in Additional file 3.
Quantitative RT-PCR was performed to: 1) compare the
abundance of chrY transcripts in hearts from C57BL/6J
and C57.YA male mice; and 2) to validate results obtained
by microarray experiments. For each primer pair, amplifi-
cation was performed using reagents from the PCR Quant-
iTect SYBR Green kit (Qiagen) and the Mx3005P
thermocycler (Stratagene, La Jolla, CA). After 40 rounds of
amplification, the specificity of each primer pair was veri-BMC Genomics 2009, 10:150 http://www.biomedcentral.com/1471-2164/10/150
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fied by increasing the temperature from 55°C to 95°C to
construct melting curves. Values were expressed by calcu-
lating the 2(-ΔCt) value, where the threshold cycle Ct repre-
sents the fractional cycle number at which the
fluorescence passes a fixed threshold, and ΔCt represents
the differences between the Ct of the gene of interest and
that of the housekeeping gene Rps16, coding for ribos-
omal protein S16 sub-unit. Each value represented the
average of 3 replicate measurements.
Genomic sequencing
Genomic DNA was extracted from hearts of adult C57BL/
6J and C57.YA using the DNeasy blood & tissue commercial
kit (Qiagen Canada, Mississauga, ON). Primers were
designed to amplify ~1 kb of upstream promoter, each
exon (including 30 bp of intron flanking sequences as
well as ~1 kb of the 3'-unstranslated region) of the Ddx3y
and Eif2s3y genes. Amplicons were then sequenced at the
McGill Genome Discovery Centre.
Abbreviations
chrY: chromosome Y; ChrYC57: chrY from the C57BL/6J
mouse strain; ChrYA : chrY from the A/J mouse strain; CM:
cardiomyocyte; CX: castration; FDR: false discovery rate;
KEGG: Kyoto Encyclopedia of Genes and Genomes.
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